MINSA DecretoDecreto Executivo n.º 1/22, de 5 de Janeiro
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
Decreto Executivo n.º 1/22, de 5 de Janeiro is the official MINSA identifier for “Condições de certificação das Farmácias e Laboratórios de Análises Clínicas para a realização de testes de antigénio para a detecção do Vírus SARS-CoV-2 que causa a COVID-19”. Decreto Executivo n.º 1/22, de 5 de Janeiro is the official identifier MINSA uses for this instrument.
- Instrument
- Decreto
- Full name
- Decreto Executivo n.º 1/22, de 5 de Janeiro
- Category
- General
- Source publication
- Portuguese
- Readable HTML
- 1 language version
- Published
- 2022-01-05
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Condições de certificação das Farmácias e Laboratórios de Análises Clínicas para a realização de testes de antigénio para a detecção do Vírus SARS-CoV-2 que causa a COVID-19
Historical Health Ministry decree with all seven articles and both annexes on SARS-CoV-2 antigen-testing service certification. It provides pharmacy authorization conditions, updated pharmacy/test lists, ReDIV reporting, two printed reporting forms and attached positive-result procedures. The Gazette is dated 5 January 2022 and the ministerial text is dated 30 December 2021. This pandemic service source is not a general device market-authorization rule; later measures and current applicability remain unverified.
Decreto Executivo n.º 1/22, de 5 de Janeiro is the official identifier MINSA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.